Joseph Saseen, PharmD, addresses statin intolerance and misinformation and provides a look at aggres...
2026 Dyslipidemia Guidelines: Earlier Screening and What's Coming Next
Joseph Saseen, PharmD, addresses statin intolerance and misinformation and provides a look at aggressive new LDL targets and emerging therapies not yet...
Author: pharmacytimes.com
Read Original Article